SCFFBXW7/GSK3β-mediated GFI1 degradation suppresses gastric cancer cell proliferation.

Gastric cancer is the third leading cause of cancer-related death worldwide. The regulatory mechanisms underlying gastric cancer cell proliferation are largely unclear. Here, we show that the transcription factor GFI1 is associated with advanced clinical gastric cancer progression and promoted gastric cancer cell proliferation partially through inhibition of gastrokine-2 (GKN2) transcription. GFI1 was a degrading substrate of FBXW7, whose loss was observed in gastric cancer. Mechanistically, GSK3β-mediated GFI1 S94/S98 phosphorylation triggered its interaction with FBXW7, resulting in SCFFBXW7-mediated ubiquitination and degradation. A nondegradable GFI1 S94A/S98A mutant was more potent in driving gastric cancer cell proliferation and tumorigenesis than wild-type GFI1. Overall, this study reveals the oncogenic role of GFI1 in gastric cancer and provides mechanistic insights into the tumor suppressor function of FBXW7. Significance: These findings demonstrate the oncogenic role of the transcription factor GFI1 and the tumor suppressive function of FBXW7 in gastric cancer.

[1]  Wenyi Wei,et al.  SCFFBW7-mediated degradation of Brg1 suppresses gastric cancer metastasis , 2018, Nature Communications.

[2]  S. Richard,et al.  GFI1 facilitates efficient DNA repair by regulating PRMT1 dependent methylation of MRE11 and 53BP1 , 2018, Nature Communications.

[3]  M. Teh,et al.  Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. , 2018, Cancer cell.

[4]  O. Elemento,et al.  Conversion of adult endothelium to immunocompetent haematopoietic stem cells , 2017, Nature.

[5]  Yingyan Yu,et al.  Fbxw7 haploinsufficiency loses its protection against DNA damage and accelerates MNU-induced gastric carcinogenesis , 2017, Oncotarget.

[6]  T. Wang,et al.  Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression. , 2016, The Journal of clinical investigation.

[7]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[8]  Jason G. Jin,et al.  Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes , 2015, Nature Medicine.

[9]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[10]  Shung-Haur Yang,et al.  FBXW7 Mutation Analysis and its Correlation with Clinicopathological Features and Prognosis in Colorectal Cancer Patients , 2015, The International journal of biological markers.

[11]  C. Liang,et al.  p53 Mutation Directs AURKA Overexpression via miR-25 and FBXW7 in Prostatic Small Cell Neuroendocrine Carcinoma , 2014, Molecular Cancer Research.

[12]  B. Clurman,et al.  Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities. , 2014, Cancer cell.

[13]  Gary D Bader,et al.  Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma , 2014, Nature.

[14]  Roopma Wadhwa,et al.  Gastric cancer—molecular and clinical dimensions , 2013, Nature Reviews Clinical Oncology.

[15]  Meijuan Zhou,et al.  Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1 , 2013, Nature Immunology.

[16]  R. Young,et al.  The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia , 2013, The Journal of experimental medicine.

[17]  I. Tomlinson,et al.  Investigation of the atypical FBXW7 mutation spectrum in human tumours by conditional expression of a heterozygous propellor tip missense allele in the mouse intestines , 2013, Gut.

[18]  A. Giraud,et al.  Gastrokines: stomach-specific proteins with putative homeostatic and tumor suppressor roles. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[19]  B. Ryffel,et al.  Stat3 and Gfi-1 transcription factors control Th17 cell immunosuppressive activity via the regulation of ectonucleotidase expression. , 2012, Immunity.

[20]  S. Gygi,et al.  SCFFbw7 Regulates Cellular Apoptosis By Targeting Mcl-1 for Ubiquitination and Destruction , 2010, Nature.

[21]  K. Mimori,et al.  p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. , 2009, Cancer research.

[22]  Joel Moss,et al.  Helicobacter pylori VacA-induced Inhibition of GSK3 through the PI3K/Akt Signaling Pathway* , 2009, Journal of Biological Chemistry.

[23]  R. Tavares,et al.  Decreased Expression of Gastrokine 1 and the Trefoil Factor Interacting Protein TFIZ1/GKN2 in Gastric Cancer: Influence of Tumor Histology and Relationship to Prognosis , 2008, Clinical Cancer Research.

[24]  John O. Trent,et al.  Mutations in growth factor independent-1 associated with human neutropenia block murine granulopoiesis through colony stimulating factor-1. , 2008, Immunity.

[25]  B. Clurman,et al.  FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation , 2008, Nature Reviews Cancer.

[26]  C. Bloomfield,et al.  A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemia. , 2007, Blood.

[27]  Jonghwan Kim,et al.  Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1. , 2007, Molecular cell.

[28]  R. Poulsom,et al.  Cytokine Regulation of the Trefoil Factor Family Binding Protein GKN2 (GDDR/TFIZ1/blottin) in Human Gastrointestinal Epithelial Cells , 2006, Cellular Physiology and Biochemistry.

[29]  S. Orkin,et al.  Gfi-1 restricts proliferation and preserves functional integrity of haematopoietic stem cells , 2004, Nature.

[30]  K. Nakayama,et al.  Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7 , 2004, The EMBO journal.

[31]  B. Clurman,et al.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  A. Behrens,et al.  The Ubiquitin Ligase SCFFbw7 Antagonizes Apoptotic JNK Signaling , 2004, Science.

[33]  K. Dou,et al.  [Down-regulated full-length novel gene GDDR and its effect on gastric cancer]. , 2003, Zhonghua yi xue za zhi.

[34]  Kyucheol Cho,et al.  Frequent monoallelic deletion of PTEN and its reciprocal associatioin with PIK3CA amplification in gastric carcinoma , 2003, International journal of cancer.

[35]  Daniel A. Haber,et al.  Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines , 2001, Nature.

[36]  N. Sasaki,et al.  Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.

[37]  P. Cohen,et al.  A common phosphate binding site explains the unique substrate specificity of GSK3 and its inactivation by phosphorylation. , 2001, Molecular Cell.

[38]  Y. Yoshikawa,et al.  Isolation of Two Novel Genes, Down‐regulated in Gastric Cancer , 2000, Japanese journal of cancer research : Gann.

[39]  Thorsten Schmidt,et al.  Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis , 1998, Oncogene.

[40]  T. Roberts,et al.  Cloning of the human Gfi-1 gene and its mapping to chromosome region 1p22 , 1997, Oncogene.

[41]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[42]  J. Ouyang,et al.  GKN2 increases apoptosis, reduces the proliferation and invasion ability of gastric cancer cells through down-regulating the JAK/STAT signaling pathway. , 2017, American journal of translational research.

[43]  Ziwei Wang,et al.  Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer. , 2016, Cancer letters.